What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. 1992.
about
Molecular markers of early Parkinson's disease based on gene expression in bloodFactors associated with ambulatory activity in de novo Parkinson diseaseParkinson's Disease and Cognitive ImpairmentIncreased free water in the substantia nigra of Parkinson's disease: a single-site and multi-site study.Longitudinal changes in free-water within the substantia nigra of Parkinson's diseaseFree-water and BOLD imaging changes in Parkinson's disease patients chronically treated with a MAO-B inhibitor.Salivary DJ-1 could be an indicator of Parkinson's disease progressionPrevalence of hypersexual behavior in Parkinson's disease patients: Not restricted to males and dopamine agonist useIs ioflupane I123 injection diagnostically effective in patients with movement disorders and dementia? Pooled analysis of four clinical trials.Daytime sleepiness in Parkinson's disease: a reappraisal.Blood oxygenation level-dependent activation in basal ganglia nuclei relates to specific symptoms in de novo Parkinson's diseaseMicrotubule destabilization is shared by genetic and idiopathic Parkinson's disease patient fibroblasts.Multipinhole collimator with 20 apertures for a brain SPECT application.Force control deficits in individuals with Parkinson's disease, multiple systems atrophy, and progressive supranuclear palsy.Subthalamic nucleus--sensorimotor cortex functional connectivity in de novo and moderate Parkinson's disease.Serum adiponectin levels in advanced-stage Parkinson's disease patients.Quantitative EEG as a predictive biomarker for Parkinson disease dementiaMutations in DJ-1 are rare in familial Parkinson diseaseSensorimotor connectivity in Parkinson's disease: the role of functional neuroimagingDifferential diagnosis of parkinsonism: a metabolic imaging study using pattern analysisParkinson's disease biomarkers program brain imaging repository.Parkinson's disease diffusion MRI is not affected by acute antiparkinsonian medication.Distinguishing essential tremor from Parkinson's disease: bedside tests and laboratory evaluations.Memory Similarities Between Essential Tremor and Parkinson's Disease: A Final Common Pathway?Trial of CBT for impulse control behaviors affecting Parkinson patients and their caregiversDifferences in brain activation between tremor- and nontremor-dominant Parkinson diseaseThalamic projection fiber integrity in de novo Parkinson disease.Lifetime occupational and leisure time physical activity and risk of Parkinson's disease.Diffusion tensor imaging of Parkinson's disease, atypical parkinsonism, and essential tremorDistinct functional and macrostructural brain changes in Parkinson's disease and multiple system atrophy.The Alterations of Cortical Volume, Thickness, Surface, and Density in the Intermediate Sporadic Parkinson's Disease from the Han Population of Mainland China.Study in Parkinson disease of exercise (SPARX): translating high-intensity exercise from animals to humansIncreased REM sleep without atonia in Parkinson disease with freezing of gaitHousehold organophosphorus pesticide use and Parkinson's disease.Dietary iron intake and risk of Parkinson's disease.Job exposure matrix (JEM)-derived estimates of lifetime occupational pesticide exposure and the risk of Parkinson's disease.Aldehyde dehydrogenase variation enhances effect of pesticides associated with Parkinson disease.Changes in functional organization and white matter integrity in the connectome in Parkinson's disease.Distant delivery of a mindfulness-based intervention for people with Parkinson's disease: the study protocol of a randomised pilot trial.Efficacy of rasagiline and selegiline in Parkinson's disease: a head-to-head 3-year retrospective case-control study.
P2860
Q24292810-45357BFB-CFBB-4F36-BC8E-8944E5AF929DQ29048640-BBC9BD25-7B30-4719-801D-065EEB520E3FQ30239814-A8B1692E-EA5F-4D3A-8FB2-7EC2E8945CBAQ30873974-913E882D-F6C2-48A7-91B6-99F4F65CDABBQ30952963-5264D30A-F6C3-4574-966F-4EDE57C114D2Q31080092-099BCFAC-64A6-4BAF-9523-DBF3B06E10FAQ33719372-AEFFF9D2-E934-490A-8F36-7C0316A939D4Q33735100-3BE7BFA4-EF2B-4E57-A679-9834EC6DC92FQ33879821-8253860D-C992-4362-9924-02E6410307F6Q34150079-F42DE258-FD84-43BE-9ED8-96412493BE63Q34185526-B37530C0-4969-4E6B-ABDD-FEAE639BE7CDQ34292484-5C11E1CA-1682-440D-9FDE-AFAD9E774893Q34445087-F1331D16-9707-4770-A15E-800AFEF9AF02Q34625773-0AA9F64D-ABA7-4B36-93AB-906B58BDBF10Q34715002-A7E08447-4FEE-4D3D-BDAD-C66FD7B8F937Q35101405-8F5BE6F3-337B-42BD-BDAB-835DC2135C7AQ35117071-838E2691-FE43-4399-BFF0-3B3D76E0701DQ35231079-F913C323-53A0-4611-AF5B-CD6DDFD62C5EQ35325681-9F9A9C52-DD71-4B91-9799-1E1542F09957Q36198606-5B37E82C-3AD8-4F5E-A03A-35DEE1E97E1BQ36276040-4C231B55-90F5-41E2-82A3-3EB7F4E91F59Q36301580-84555C58-B644-48E9-ACCA-8C8D67C41AF0Q36331828-572BDEB8-1B4B-452D-B98E-5A46CCA7A50EQ36535822-DA87DE7E-98FE-4758-8E0E-42D4234AC644Q36687142-2CC0A6EE-2232-4B6E-82F7-FCCF83FE53CCQ36818397-A031A518-46CE-4531-8719-F68FB35742FBQ36893101-9E368E3F-BAC9-4896-9E47-568024679651Q37022711-EF1A0B98-4EF4-4D83-8C19-BB090A2EB985Q37106984-642AEE0D-F76A-4B88-96AC-E54D1AAF41CFQ37108101-B66B9279-2454-4A36-B51C-FFD6696BAFBDQ37146896-3584FEFD-30F2-4CDF-95A3-17F1C1DA0E6FQ37161380-9314693A-03BE-47B2-A785-40832F280847Q37227018-F3A17A44-6B1B-46D4-AB65-E78CA9C01685Q37253501-8F6F0D04-66D0-40C8-85D1-DE67ED7C38B5Q37305887-5B2903E5-1B41-4B4D-A3A6-5D222D920866Q37565100-6D1592FF-A7D5-483C-B6CB-18FF233EE646Q37567487-DE750754-B82E-4F9C-B791-12CA6F5AA46CQ37580673-AA333C31-4326-47EC-92E2-AF0B5FD7EDF2Q37593613-1C9C09E4-C3D1-4B80-B95F-90421EBE2BA2Q38760546-A87E06BF-C00D-40F6-B8E9-FEB5BA65DD55
P2860
What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. 1992.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
What features improve the accu ...... clinicopathologic study. 1992.
@ast
What features improve the accu ...... clinicopathologic study. 1992.
@en
type
label
What features improve the accu ...... clinicopathologic study. 1992.
@ast
What features improve the accu ...... clinicopathologic study. 1992.
@en
prefLabel
What features improve the accu ...... clinicopathologic study. 1992.
@ast
What features improve the accu ...... clinicopathologic study. 1992.
@en
P2093
P1433
P1476
What features improve the accu ...... clinicopathologic study. 1992
@en
P2093
A J Hughes
S E Daniel
Y Ben-Shlomo
P407
P433
10 Suppl 3
P577
2001-11-01T00:00:00Z